JP2014505702A5 - - Google Patents

Download PDF

Info

Publication number
JP2014505702A5
JP2014505702A5 JP2013552560A JP2013552560A JP2014505702A5 JP 2014505702 A5 JP2014505702 A5 JP 2014505702A5 JP 2013552560 A JP2013552560 A JP 2013552560A JP 2013552560 A JP2013552560 A JP 2013552560A JP 2014505702 A5 JP2014505702 A5 JP 2014505702A5
Authority
JP
Japan
Prior art keywords
nutritional composition
protein
provides
omega
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013552560A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014505702A (ja
JP6034805B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/022726 external-priority patent/WO2012106179A1/en
Publication of JP2014505702A publication Critical patent/JP2014505702A/ja
Publication of JP2014505702A5 publication Critical patent/JP2014505702A5/ja
Application granted granted Critical
Publication of JP6034805B2 publication Critical patent/JP6034805B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013552560A 2011-02-02 2012-01-26 高タンパク質栄養組成物並びにその製造方法及び使用方法 Active JP6034805B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161438804P 2011-02-02 2011-02-02
US61/438,804 2011-02-02
PCT/US2012/022726 WO2012106179A1 (en) 2011-02-02 2012-01-26 High protein nutritional compositions and methods of making and using same

Publications (3)

Publication Number Publication Date
JP2014505702A JP2014505702A (ja) 2014-03-06
JP2014505702A5 true JP2014505702A5 (enExample) 2016-11-04
JP6034805B2 JP6034805B2 (ja) 2016-11-30

Family

ID=45554910

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013552560A Active JP6034805B2 (ja) 2011-02-02 2012-01-26 高タンパク質栄養組成物並びにその製造方法及び使用方法

Country Status (14)

Country Link
US (1) US9930908B2 (enExample)
EP (1) EP2670262B2 (enExample)
JP (1) JP6034805B2 (enExample)
CN (1) CN103347403B (enExample)
AU (3) AU2012212591A1 (enExample)
BR (1) BR112013019677B1 (enExample)
CA (1) CA2824591C (enExample)
ES (1) ES2882806T5 (enExample)
MX (1) MX2013009007A (enExample)
PH (1) PH12013501433A1 (enExample)
RU (1) RU2013140443A (enExample)
SG (1) SG191428A1 (enExample)
WO (1) WO2012106179A1 (enExample)
ZA (1) ZA201306543B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2824591C (en) 2011-02-02 2019-02-05 Nestec S.A. High protein nutritional compositions and methods of making and using same
AU2014225786B2 (en) 2013-03-08 2017-10-12 Axiom Foods, Inc. Rice protein supplements
EP3082465A2 (en) * 2013-12-19 2016-10-26 Abbott Laboratories Nutritional composition comprising hydrolyzed protein
CN105212042A (zh) * 2014-06-30 2016-01-06 罗汉斐 一种小麦发酵营养食品及其制作方法
CN110868870A (zh) 2017-05-12 2020-03-06 艾斯姆食品公司 大米产物及制备它们的系统和方法
US10806169B2 (en) 2018-05-15 2020-10-20 Kate Farms, Inc. Hydrolyzed pea protein-based nutrient composition
US12558370B2 (en) 2018-06-12 2026-02-24 Kate Farms, Inc. Intact pea protein-based nutrient composition
CN112367848A (zh) * 2018-06-14 2021-02-12 马斯公司 用于支持患有癌症的动物的组合物
US11058139B2 (en) * 2018-07-03 2021-07-13 Kerri Ann Langhorne Recovery supplement for horses
MX2021005925A (es) 2018-11-20 2021-06-30 Fonterra Cooperative Group Ltd Proceso y producto lacteo.
FR3093427B1 (fr) * 2019-03-05 2021-03-05 Mativa Tech Composition pour son utilisation dans la prévention et/ou le traitement de la dysbiose
JP2022534471A (ja) * 2019-05-31 2022-08-01 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 動物における健康効果を提供するためのmctベースの栄養ブレンド
AR120346A1 (es) * 2019-10-31 2022-02-09 Idemitsu Kosan Co Agente para suprimir la resistencia a la insulina en rumiantes

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6140304A (en) * 1988-09-28 2000-10-31 Eicotech Corporation Method of and nutritional and pharmaceutical compositions for reduction of hyperinsulinemia
US5714472A (en) † 1993-12-23 1998-02-03 Nestec Ltd. Enternal formulation designed for optimized nutrient absorption and wound healing
DE69525150T2 (de) † 1994-04-01 2002-09-05 Abbott Laboratories, Abbott Park Nahrungsprodukt zur behandlung der ulzerativen kolitis sowie verwendung desselben
US5776913A (en) 1995-10-10 1998-07-07 Colgate Palmolive Company Therapeutic diet for metabolic abnormalities found in animals with lymphoma
CN1221249C (zh) * 1998-08-19 2005-10-05 斯凯伊药品加拿大公司 普鲁泊福的可注射水分散体
US20040121044A1 (en) * 2001-03-14 2004-06-24 John Tiano Nutritional product with high protein, low carbohydrate content and good physical stability
EP1383445A4 (en) * 2001-03-20 2005-04-13 Cydex Inc FORMULATIONS WITH PROPOFOL AND A SULFOALKYL ETHER CYCLODEXTRIN
SE526943C2 (sv) 2002-08-26 2005-11-22 Indevex Ab Födoämneskompositionsprodukt
US20040225022A1 (en) † 2003-05-09 2004-11-11 Desai Neil P. Propofol formulation containing reduced oil and surfactants
US20060280776A1 (en) * 2003-09-02 2006-12-14 Masafumi Koide Diet food
US7759507B2 (en) * 2003-09-05 2010-07-20 Abbott Laboratories Lipid system and methods of use
EP1723951A1 (en) † 2005-04-21 2006-11-22 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
JP5667737B2 (ja) * 2004-07-01 2015-02-12 ネステク ソシエテ アノニム イヌ変形性関節症食餌製剤
JP5574561B2 (ja) * 2004-09-22 2014-08-20 味の素株式会社 総合経腸栄養組成物
CA2620366C (en) * 2005-08-26 2014-04-01 Nestec S.A. Nutrition for obese patients
US20070166411A1 (en) * 2005-12-16 2007-07-19 Bristol-Myers Squibb Company Nutritional supplement containing long-chain polyunsaturated fatty acids
EP1971230A2 (en) † 2006-01-09 2008-09-24 Nestec S.A. Treatment of stressed patients
JP5118125B2 (ja) * 2006-03-23 2013-01-16 ネステク ソシエテ アノニム 高カロリーの栄養補助食品
GB0612671D0 (en) * 2006-06-27 2006-08-09 Shs Int Ltd Nutritional formulation
PT2374452T (pt) † 2008-12-05 2019-10-31 Ajinomoto Kk Composição de nutrientes
CA2824591C (en) † 2011-02-02 2019-02-05 Nestec S.A. High protein nutritional compositions and methods of making and using same

Similar Documents

Publication Publication Date Title
MY189576A (en) Omega-3 fatty acid ester compositions
PH12013501433A1 (en) High protein nutritional compositions and methods of making and using same
PH12017500074A1 (en) Nutritional compositions containing oil blends and uses thereof
GB2459809A (en) Fatty acid formulations and methods of use thereof
PH12015502307A1 (en) Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form
WO2013123139A8 (en) Methods, compositions, and devices for supplying dietary fatty acid needs
WO2013153071A3 (en) A nutritional composition
RU2013146517A (ru) Композиции и способы, пригодные для облегчения возрастных заболеваний
PH12016500026A1 (en) Nutritional compositions containing synergistic combination and uses thereof
PH12018500090A1 (en) Nutritional compositions and methods for promoting cognitive development
AR105144A1 (es) Composiciones nutricionales y métodos para promover el desarrollo cognitivo
PH12018500036A1 (en) Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid
MX2012008081A (es) Composiciones que comprenden extractos de andrographis paniculata y ginkgo biloba combinados con fosfolipidos.
RU2016129079A (ru) Композиции омега-3 жирных кислот для лечения заболеваний, вызывающих поражение нервной системы
MX2015002568A (es) Grasa con bajo contenido de acidos grasos saturados para recubrimiento de productos de confiteria.
BR112014024523A2 (pt) sistema de gordura de panificação
MX2016008287A (es) Composicion que comprende sacarato ferrico y concentraciones altas de lc-pufa microencapsulado con un sabor desagradable reducido.
WO2015095570A3 (en) Nutritional composition comprising hydrolyzed protein
WO2014008465A3 (en) Potentiation of antibiotic treatment with a protein-lipid complex
PH12020550961A1 (en) Stabilizing omega-3 fatty acids with bran
ES2413497B1 (es) Composición con alto contenido en Omega 3, Omega 6 y Omega 9
EA201692398A1 (ru) Гомогенная композиция для перорального введения, содержащая омега-3 полиненасыщенные жирные кислоты и ресвератрол
UA108535U (uk) Аліментарний спосіб профілактики та лікування дисбіотичних захворювань
Kiefer Nutrients for Macular Degeneration: An RCT
Velikaja et al. Polyunsaturate fatty acids as a source of longevity